Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  Roche Holding Ltd.    RHO5   CH0012032048

Delayed Quote. Delayed  - 08/25 06:05:13 pm
220.634 EUR   -1.10%
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting -- 3r..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on ROCHE HOLDING LTD.
08/25 ELEVEN BIOTHERAPEUTICS : Reports Second Quarter 2016 Financial Results and Provi..
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting
08/25DJStocks Fall as Investors Look to Fed's Jackson Hole Meeting -- 3rd Update
08/25 ROCHE : Nutley township arranges break for medical school
08/25DJShares Fall as Health-Care Sector Loses Ground -- Update
08/25 ROCHE : This year, Roche and Lucerne Festival present the eighth Roche Commissio..
08/23 HONEYWELL INTERNATIONAL : Federal Contracts Awarded to Companies in Indiana (Aug..
08/23 ROCHE : Federal Contracts Awarded by Federal Agencies in Hawaii (Aug. 23)
08/23 ROCHE : Sources Sought - REAGENTS FOR THE ROCHE 4800
08/23 ROCHE : MILITARY $898,890 Federal Contract Awarded to Roche Diagnostics
08/23 ROCHE : Sources Sought Notice - 66-- REAGENTS FOR THE ROCHE 4800
08/23 ROCHE : launches innovative Accu-Chek Guide blood glucose monitoring system, whi..
08/23 ROCHE : launches innovative Accu-Chek® Guide blood glucose monitoring system, th..
08/20 ROCHE : Federal Contracts Awarded to Companies in Indiana (Aug. 20)
08/20 ROCHE : MILITARY $6 Million Federal Contract Awarded to Roche Diagnostics
08/18 CHUGAI PHARMACEUTICAL : Findings from Chugai Pharmaceutical in the Area of Osteo..
08/18 ROCHE : State aid, transit project on hold
08/18 ARRAY BIOPHARMA : Genentech Assigned Patent
08/17 ROCHE : Combined Synopsis/Solicitation - 674-17-1-034-0007 Roche 4800
08/17 ROCHE : Combine Solicitation - 65-- 674-17-1-034-0007 Roche 4800
08/17 #WOMENSMONTH : Partnership to improve breast cancer care in Kenya
08/15 ROCHE : Partnership to Improve Breast Cancer Care Launches in Kenya
08/15 ROCHE : Partnership to Improve Breast Cancer Care Launches in Kenya First Lady M..
08/11 FOUNDATION MEDICINE : FoundationOne® Accepted by FDA and CMS for Parallel Review..
08/11 ROCHE : Combine Solicitation - Purchase of Roche MagNA Pure 96 DNA and Viral NA ..
08/11 OLD MUTUAL : Roche, Old Mutual Nigeria Partner to Develop Insurance Product for ..
08/11 ROCHE : Breast cancer patients to access advanced diagnostic equipment at Kenyat..
08/11DJBusiness Watch -- WSJ
08/11 ROCHE : dynamic development management tool deductions - Department of Vendee
08/11 CANCER VACCINES : Abzena and Genentech go Under the Microscope in Exclusive New ..
08/10 ROCHE : Clyde's Camp gives dogs a new escape
08/10 ROCHE : 'Roche Continents' at the Salzburg Festival celebrates its 10th annivers..
08/09 ROCHE : Hosts Virtual Reality Theater
08/09 OLD MUTUAL : Roche, Old Mutual Partner On Insurance Product for Terminal Illness..
08/05 ROCHE : acquisition of a floor area of artistic gymnastics
08/05DJBristol-Myers Shares Sink as Lung-Cancer Drug Misses Goal
08/04 CHUGAI PHARMACEUTICAL : Studies from Chugai Pharmaceutical Have Provided New Inf..
08/04 ROCHE : Inovio pursues Hepatitis B treatment without Roche
08/03 ROCHE : Genentech brings STEM to kids
08/02 FOUNDATION MEDICINE : reports 2Q loss
08/02 FOUNDATION MEDICINE, INC. : Entry into a Material Definitive Agreement, Results ..
08/02 ROCHE : receives CLIA waiver for cobas Influenza A/B & RSV test for the cobas Li..
07/31 ROCHE : National approach needed in fight against Hepatitis
07/30 ROCHE : Spatial passing Roche
07/29 ROCHE : oeuvre management assignment for the lighting of the cathedral our lady ..
07/28 Chugai and Galderma Announce Global License Agreement for Nemolizumab CIM331,..
07/28 ROCHE : Sources Sought Notice - 65-- Roche Diagnostics Corp Histology Supplies f..
07/28 ROCHE : Township adopts roche phase 1 redevelopment plan
07/28 ROCHE : emicizumab continued to show promising safety and efficacy profile in lo..
07/27DJExperimental Alzheimer's Drug Fails in Trial
07/27 GSK chases next biotech asthma drug with 175 million pounds J&J deal
07/27 ROCHE : Architectural, engineering and planning services
07/22 ROCHE : F. Hoffmann-La Roche Announces Half Year Results 2016
07/22 ROCHE : Diagnostics Operations Assigned Patent
07/22 ROCHE : Site finds its buyer
07/22 UNILEVER : and Roche results better than expected
07/21DJAmgen and Allergan Study Finds Biosimilar Comparable to Herceptin
07/21 ROCHE : Bloomfield firm buys roche campus; medical school lease signed
07/21 ROCHE : S campus sold; lease signed for medical school
07/21DJROCHE : Sales Rise on Cancer Drugs -- Update
07/21DJROCHE : Sales Rise on Cancer Drugs
07/21DJROCHE : Net Profit Up 4% in First Half
07/21DJROCHE : 1st Half Net Profit Up 4% to CHF5.5 Billion
07/19 ROCHE : Genentech Provides Update on Phase III Study of Gazyva in People with Pr..
07/18DJROCHE : 1st Half 2016 -- Forecast
07/18 ROCHE : provides update on phase III study of Gazyva/Gazyvaro in people with pre..
07/18 GENENTECH : Provides Update on Phase III Study of Gazyva® in People With Previou..
07/15 ROCHE : After all these years ... Berry Pond still beloved by locals
07/14 REMINDER : Invitation to Roche's Half Year Results 2016
07/14DJCravath, Swaine & Moore Names Faiza Saeed as Presiding Partner
07/13 BioMarin Pharmaceutical shares rise after possible takeover from Roche
07/12 FOUNDATION MEDICINE INC. : COO Sells $114,766.65 in Stock
07/12 ROCHE : FDA Approves Xolair for Allergic Asthma in Children 6-11
07/11 ROCHE : FDA approves Xolair to treat allergic asthma in children
1  2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ( CHF)
Sales 2016 51 267 M
EBIT 2016 18 023 M
Net income 2016 11 303 M
Debt 2016 11 050 M
Yield 2016 3,52%
P/E ratio 2016 18,24
P/E ratio 2017 16,35
EV / Sales 2016 4,32x
EV / Sales 2017 4,00x
Capitalization 210 373 M
More Financials
Chart ROCHE HOLDING LTD.
Duration : Period :
Roche Holding Ltd. Technical Analysis Chart | RHO5 | CH0012032048 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 300  CHF
Spread / Average Target 23%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Severin Schwan Chief Executive Officer & Executive Director
Christoph Franz Chairman
Daniel O'Day COO-Roche Pharmaceuticals Division
Roland Diggelmann COO-Roche Diagnostics Division
Alan Hippe Chief Financial & Information Technology Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ROCHE HOLDING LTD.-12.41%217 694
JOHNSON & JOHNSON15.57%324 776
ROCHE HOLDING LTD.-11.47%217 694
NOVARTIS AG-9.45%213 882
PFIZER INC.7.87%211 206
MERCK & CO., INC.18.76%173 462
More Results